Home › Funds › Navera Investment Management Ltd. › BSX

Navera Investment Management Ltd. position in BSX

BOSTON SCIENTIFIC CORP · Health Care

Navera Investment Management Ltd. reported holding 1,369,614 shares of BSX (BOSTON SCIENTIFIC CORP) in its Q3 2026 13F filing — a position valued at US$59.8M, representing 1.59% of its reported portfolio and ranking #24 among its reported holdings. Navera Investment Management Ltd. has disclosed BSX holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)1.37M sh
Reported value held$59.80M
Portfolio Weight1.59%
First reportedQ1 2026
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Navera Investment Management Ltd.'s BSX position evolved

Navera Investment Management Ltd. first disclosed a stake in BSX in Q1 2026 at 1,558,014 shares (US$97.7M). Across 3 filings, Navera Investment Management Ltd. increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,369,614 shares valued at US$59.8M — a reduction of -57,978 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q1 2026 1.56M $97.75M New
Q2 2026 1.43M $60.93M Reduce
Q3 2026 1.37M $59.80M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BSX and 13F data

BSX (BOSTON SCIENTIFIC CORP) is a Health Care company. 18 other funds we track also report a position in BSX — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$2.56B), MFS Investment Management (US$2.29B), D. E. Shaw & Co (US$1.16B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BSX

All BSX fund holders →

FAQ

How long has Navera Investment Management Ltd. held BSX?

Navera Investment Management Ltd. has disclosed BSX holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is Navera Investment Management Ltd.'s current position in BSX?

As of Q3 2026, Navera Investment Management Ltd. holds 1.37M shares of BSX (BOSTON SCIENTIFIC CORP), valued at $59.80M, representing 1.59% of its reported portfolio and ranking #24.

Has Navera Investment Management Ltd. been buying or selling BSX?

In the latest 13F filing (Q3 2026), Navera Investment Management Ltd. reduced its position in BSX.

Which other funds hold BSX?

Other major institutional holders of BSX include PRIMECAP MANAGEMENT CO/CA/, MFS Investment Management, D. E. Shaw & Co, among 18 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.